Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

Substance use disorders are rarely, if ever, isolated concerns. Substance use is often a response to unaddressed mental health challenges, trauma, and unmet needs, and should be treated as such.

Nearly 50 million people in the United States struggle with substance use disorders, and nearly three in four use more than one substance. People with polysubstance use disorders are more likely than ...

Participants in an IFS PTSD-SUD (substance use disorder) intervention experienced reduced PTSD symptoms and cravings, making it a promising public health treatment option.

Substance use and substance use disorder differ by the frequency of use and the effect on a person’s life. Substance use disorder is a mental health condition. Substance use refers to using both legal ...

Researchers at Washington University School of Medicine in St. Louis show in a new study that GLP-1 medications may be ...

Nearly 19 million children in the United States have at least one parent with a substance use disorder, according to a new study published Monday in JAMA Pediatrics. And a significant number of those ...

Although drug overdose deaths declined in the U.S. last year, the rate of substance use disorder is rising, and the problem ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...